-
1
-
-
0034737962
-
What Makes Clinical Research Ethical
-
2703
-
E. Emanuel, C. Grady & D. Wendler. What Makes Clinical Research Ethical. JAMA. 2000; 283: 2701-2711: 2703.
-
(2000)
JAMA
, vol.283
, pp. 2701-2711
-
-
Emanuel, E.1
Grady, C.2
Wendler, D.3
-
2
-
-
84929515319
-
-
http://www.hhs.gov/ohrp/archive/nurcode.html
-
-
-
-
3
-
-
84930781622
-
-
note 1
-
Emanuel et al., op. cit. note 1. p. 2703.
-
op. cit.
, pp. 2703
-
-
Emanuel1
-
4
-
-
84872129305
-
A Non-Paternalistic Model of Research Oversight: Assessing the Benefits of Prospective Review
-
932
-
A. London. A Non-Paternalistic Model of Research Oversight: Assessing the Benefits of Prospective Review. J Law Med Ethics 2012; 40: 930-944, p. 932.
-
(2012)
J Law Med Ethics
, vol.40
, pp. 930-944
-
-
London, A.1
-
5
-
-
66349117581
-
The Life You Can Save
-
New York: Random House
-
P. Singer. The Life You Can Save. New York: Random House; 2012.
-
(2012)
-
-
Singer, P.1
-
6
-
-
0023452835
-
Scientific Value and Validity as Ethical Requirements for Research: A proposed Explication
-
8
-
B. Freedman. Scientific Value and Validity as Ethical Requirements for Research: A proposed Explication. IRB: Ethics and Hum Beh. 1987; 9: 7-10, p. 8.
-
(1987)
IRB: Ethics and Hum Beh.
, vol.9
, pp. 7-10
-
-
Freedman, B.1
-
8
-
-
84944378249
-
-
London note 6
-
London, op. cit. note 6, p. 942
-
op. cit.
, pp. 942
-
-
-
9
-
-
0034573353
-
Defining and Describing Benefit Appropriately in Clinical Trials
-
333
-
N. King. Defining and Describing Benefit Appropriately in Clinical Trials. J Law Med Ethics. 2000; 28: 332-343, p. 333.
-
(2000)
J Law Med Ethics
, vol.28
, pp. 332-343
-
-
King, N.1
-
10
-
-
84872497150
-
Is Payment a Benefit
-
A. Wertheimer. Is Payment a Benefit. Bioethics. 2013; 27: 105-116.
-
(2013)
Bioethics
, vol.27
, pp. 105-116
-
-
Wertheimer, A.1
-
11
-
-
84929514442
-
Office of Human Subjects Research, Information Sheet 20
-
NIH, Office of Human Subjects Research, Information Sheet 20. http://oshr.od.nih.gov/info/sheet20.html
-
-
-
-
12
-
-
84929508832
-
-
Emanuel, note 1
-
Emanuel, op. cit., note 1, p. 2705.
-
op. cit.
, pp. 2705
-
-
-
13
-
-
84929512514
-
-
Belmont Report, 1979 http://ohsr.od.nih.gov/guidelines/belmont .html
-
(1979)
-
-
-
14
-
-
85115146940
-
Doctor, First Tell Me What It Costs
-
New York Times, November
-
P. Ubel. 'Doctor, First Tell Me What It Costs', New York Times, November 3, 2013.
-
(2013)
, vol.3
-
-
Ubel, P.1
-
15
-
-
84929508521
-
UVM Will Make People Sick to Test an Experimental Cholera Vaccine
-
Seven Days. August 14
-
K. Picard. UVM Will Make People Sick to Test an Experimental Cholera Vaccine. Seven Days. August 14, 2013.
-
(2013)
-
-
Picard, K.1
-
16
-
-
84929508832
-
-
Cassarett, note 10
-
Cassarett, op. cit. note 10, p. 5.
-
op. cit.
, pp. 5
-
-
-
17
-
-
85060670356
-
Thinking Further About Value
-
p. 8.
-
C. Grady. Thinking Further About Value. IRB: Ethics & Human Behavior 2002; 24: 7-8, p. 8.
-
(2002)
IRB: Ethics & Human Behavior
, vol.24
, pp. 7-8
-
-
Grady, C.1
-
18
-
-
80051605726
-
A Framework for Risk-Benefit Evaluations in Biomedical Research
-
p. 144.
-
A. Rid & D. Wendler. A Framework for Risk-Benefit Evaluations in Biomedical Research. Kennedy Inst Ethics J. 2011; 21: 141-179, p. 144.
-
(2011)
Kennedy Inst Ethics J.
, vol.21
, pp. 141-179
-
-
Rid, A.1
Wendler, D.2
-
19
-
-
84929513686
-
-
London, note 6
-
London, op cit. note 6, p. 942.
-
op cit.
, pp. 942
-
-
-
20
-
-
84944378249
-
-
London, note 6
-
London, op. cit. note 6, p. 932.
-
op. cit.
, pp. 932
-
-
|